
About Vensica Medical
Vensica Medical is a Healthcare company based in Tel Aviv (Israel) founded in 2014. Catheters for ultrasound-guided drug delivery to the bladder are developed. Vensica Medical has raised $32.5 million across 4 funding rounds from investors including The Trendlines Group, Laborie Medical and Cogentix Medical. Vensica Medical offers products and services including Vibe and ViXe. Its focus areas include Life Sciences, Genitourinary Disorders, Medical Devices and Therapeutics.
Company details
Vensica Medical was founded in 2014 in Tel Aviv, Israel, within the medical device sector focused on urology. Drug delivery catheters are developed for bladder conditions, with the VensiCare device enabling ultrasound application to the bladder prior to drug instillation. Operations center on innovative solutions for targeted therapies, serving healthcare needs in noninvasive treatments.
- Headquarters Tel Aviv, Israel
- SectorsHealthcare
- Website vensica.com
- Social LinkedIn
- Total Equity Funding$32.5M (USD)
in 4 rounds
- Latest Funding Round$11M (USD), Series B
Nov 2024
- InvestorsThe Trendlines Group
& 6 more
Products & Services of Vensica Medical
Vensica Medical offers a comprehensive portfolio of products and services, including Vibe and ViXe.
Needle-free ultrasound platform for targeted drug delivery in urology.
Combines neurotoxin with ultrasound for bladder wall treatments.
Funding Insights of Vensica Medical
Vensica Medical has successfully raised a total of $32.5M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $11 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $32.5M
- Total Rounds 4
- Last Round Series B β $11M
- First Round $500,000
(Jul 2016)
- Investors Count 7
All 4 funding rounds of Vensica Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | $11M | Series B | β | Israel Biotech Fund | |
| Nov 2021 | $19M | Series B | β | Israel Biotech Fund | |
| Sep 2017 | $2M | Series A | β | β | |
| Jul 2016 | $500,000 | Seed | β | β | β |
7 investors in total: 6 institutional and 1 angel.
Investors in Vensica Medical
Vensica Medical has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include The Trendlines Group, Laborie Medical and Cogentix Medical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| ibf.fund | ||||
Venture capital fund and startup incubator for healthcare and agricultural companies | 1993 | trendlines.com | Misgav, Israel | |
Merz is recognized as a leader in aesthetic medicine and neurotoxin therapy. | 1918 | merz.com | Frankfurt am Main, Germany | |
Medical products for female lower urinary tract dysfunctions are provided. | 1967 | laborie.com | Mississauga, Canada | |
Supplies quality tractor parts, accessories, and spares for modern and vintage models. | 2000 | agrilineproducts.com | Bromsgrove, United Kingdom | |
Minimally invasive treatment of voiding dysfunctions and endoscopy solution | 1987 | cogentixmedical.com | Orangeburg, United States | |
LP Lew Pell | unknown_ecb04d15578c4b16a |
Investor details for Vensica Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Vensica Medical
3 people are tracked at Vensica Medical (2 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Avner Geva | CEO | Leadership |
Avi Eftel | CTO | Leadership |
Noa Raish | R&d Project Manager | Team |
Complete people profiles for Vensica Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Vensica Medical
3 dated milestones of Vensica Medical across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Vensica Medical is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Series B, of $11.0M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vensica Medical
Complete news archive for Vensica Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vensica Medical
Vensica Medical was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Vensica Medical is headquartered in Tel Aviv, Israel.
Vensica Medical is a funded company, having raised a total of $32.5M across 4 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Jul 2016.
Vensica Medical was founded in 2014 in Tel Aviv, Israel, within the medical device sector focused on urology. Drug delivery catheters are developed for bladder conditions, with the VensiCare device enabling ultrasound application to the bladder prior to drug instillation. Operations center on innovative solutions for targeted therapies, serving healthcare needs in noninvasive treatments.
Vensica Medical offers Vibe and ViXe.
Vensica Medical has 7 investors. Key investors include The Trendlines Group, Laborie Medical, Cogentix Medical, Israel Biotech Fund, and Merz.
